Tymora Analytical Operations
Biopsy-free cancer detection and monitoring
Tymora Analytical Operations provides diagnostic development, contract services and products for improved cancer research. Tymora's primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow detection of active cancer markers directly from plasma, urine or saliva. The company's initial focus is on non-invasive detection and monitoring of bladder cancer from urine.